Literature DB >> 32057802

Learned avoidance requires VTA KOR-mediated reductions in dopamine.

Mykel A Robble1, Mary E Bozsik2, Daniel S Wheeler3, Robert A Wheeler4.   

Abstract

Proper learning from an aversive experience is essential for survival, yet it is an aberrant process in a wide range of mental disorders, as well as dopaminergic neurodegenerative disease. While the mesolimbic dopamine system is known to be essential for reward learning, the characterization of a potential pattern of dopamine signaling that guides avoidance remains unknown. Aversive stimuli may directly modulate dopamine signaling through the dynorphin/kappa opioid receptor (KOR) system, as kappa opioid receptors are expressed in this neural circuit and their activation is aversive in both rodents and humans. Ventral tegmental area (VTA) KORs are ideally positioned to directly shape aversion-induced reductions in dopamine signaling, but their role in this process has received little consideration. To determine the necessity of VTA KOR activity in the regulation of dopamine signaling and avoidance, we tested the effects of VTA KOR blockade on real time dopaminergic responses to aversive stimuli and learned avoidance in male Sprague-Dawley rats. We found that blockade of VTA KORs attenuated aversion-induced reductions in dopamine, and this treatment also prevented avoidance following the aversive experience. To determine whether aversion-induced reductions in striatal dopamine are necessary for avoidance, we tested avoidance following treatment with an intra nucleus accumbens D2 receptor agonist. This treatment also prevented avoidance and is consistent with the view that aversion-induced reductions in dopamine reduce dopamine signaling at high affinity D2 receptors and disinhibit an aversion-sensitive striatal output circuit to promote avoidance.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Avoidance; Dopamine; Kappa opioid receptor; Learning

Mesh:

Substances:

Year:  2020        PMID: 32057802      PMCID: PMC7080572          DOI: 10.1016/j.neuropharm.2020.107996

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  56 in total

1.  Resolving neurotransmitters detected by fast-scan cyclic voltammetry.

Authors:  Michael L A V Heien; Michael A Johnson; R Mark Wightman
Journal:  Anal Chem       Date:  2004-10-01       Impact factor: 6.986

2.  A Neural Circuit Mechanism for Encoding Aversive Stimuli in the Mesolimbic Dopamine System.

Authors:  Johannes W de Jong; Seyedeh Atiyeh Afjei; Iskra Pollak Dorocic; James R Peck; Christine Liu; Christina K Kim; Lin Tian; Karl Deisseroth; Stephan Lammel
Journal:  Neuron       Date:  2018-11-29       Impact factor: 17.173

3.  Psychotomimesis mediated by kappa opiate receptors.

Authors:  A Pfeiffer; V Brantl; A Herz; H M Emrich
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

4.  GABA neurons of the VTA drive conditioned place aversion.

Authors:  Kelly R Tan; Cédric Yvon; Marc Turiault; Julie J Mirzabekov; Jana Doehner; Gwenaël Labouèbe; Karl Deisseroth; Kay M Tye; Christian Lüscher
Journal:  Neuron       Date:  2012-03-21       Impact factor: 17.173

5.  Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors.

Authors:  Takatoshi Hikida; Satoshi Yawata; Takashi Yamaguchi; Teruko Danjo; Toshikuni Sasaoka; Yanyan Wang; Shigetada Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

6.  Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study.

Authors:  A Mansour; C A Fox; S Burke; F Meng; R C Thompson; H Akil; S J Watson
Journal:  J Comp Neurol       Date:  1994-12-15       Impact factor: 3.215

7.  Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.

Authors:  P Svenningsson; M Lindskog; C Ledent; M Parmentier; P Greengard; B B Fredholm; G Fisone
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

8.  Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward.

Authors:  Mary Kay Lobo; Herbert E Covington; Dipesh Chaudhury; Allyson K Friedman; HaoSheng Sun; Diane Damez-Werno; David M Dietz; Samir Zaman; Ja Wook Koo; Pamela J Kennedy; Ezekiell Mouzon; Murtaza Mogri; Rachael L Neve; Karl Deisseroth; Ming-Hu Han; Eric J Nestler
Journal:  Science       Date:  2010-10-15       Impact factor: 47.728

9.  Dopamine neurons projecting to the posterior striatum reinforce avoidance of threatening stimuli.

Authors:  William Menegas; Korleki Akiti; Ryunosuke Amo; Naoshige Uchida; Mitsuko Watabe-Uchida
Journal:  Nat Neurosci       Date:  2018-09-03       Impact factor: 24.884

10.  Striatal dopamine neurotransmission: regulation of release and uptake.

Authors:  David Sulzer; Stephanie J Cragg; Margaret E Rice
Journal:  Basal Ganglia       Date:  2016-08
View more
  5 in total

Review 1.  Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions.

Authors:  Lloyd D Fricker; Elyssa B Margolis; Ivone Gomes; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2020-06-02       Impact factor: 4.436

2.  A midbrain dynorphin circuit promotes threat generalization.

Authors:  Lizz Fellinger; Yong S Jo; Avery C Hunker; Marta E Soden; Jordan Elum; Barbara Juarez; Larry S Zweifel
Journal:  Curr Biol       Date:  2021-08-12       Impact factor: 10.900

Review 3.  Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.

Authors:  Kaitlin C Reeves; Nikhil Shah; Braulio Muñoz; Brady K Atwood
Journal:  Front Mol Neurosci       Date:  2022-06-15       Impact factor: 6.261

4.  Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours.

Authors:  Catherine S Thomas; Aida Mohammadkhani; Madiha Rana; Min Qiao; Corey Baimel; Stephanie L Borgland
Journal:  Neuropsychopharmacology       Date:  2021-10-18       Impact factor: 7.853

5.  Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System.

Authors:  Joseph R Driscoll; Tanya L Wallace; Kasra A Mansourian; William J Martin; Elyssa B Margolis
Journal:  eNeuro       Date:  2020-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.